Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Dimebutic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimebutic Acid SCHEMBL28581861 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL13517329 | 0.94 | — | — | |
| Dimebutic Acid SCHEMBL8748037 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL28444778 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL8383026 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL1964556 | 0.94 | — | — | |
| Dimebutic Acid SCHEMBL8383022 | 0.94 | FFAR3 (0.35) | — | |
| Dimebutic Acid SCHEMBL2990627 | 0.94 | — | — | |
| Dimebutic Acid SCHEMBL15022227 | 0.94 | — | — | |
| Dimebutic Acid SCHEMBL1055425 | 0.94 | FFAR3 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1056 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736257-A1 | METHOD FOR DISMANTLING BATTERIES, INVOLVING DEEP DISCHARGING AND ENERGY RECOVERY | SUEZ International (FR) | 2026-05-06 | — | — | EP | claimed |
| US-20260021186-A1 | Fatty Acid-D-Amino Acid Peptides Conjugates as Anaplerotic Compounds for Use in Treating Propionic Acidemia, Methylmalonic Acidurias, and Energy Metabolic Disorders | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-01-22 | — | — | US | claimed |
| EP-4389463-B1 | METHOD AND DEVICE FOR DETERMINING TIRE WEARS | TOYOTA MOTOR CO LTD (JP) | 2025-08-20 | — | — | EP | claimed |
| CN-120163839-A | Iris rapid and accurate segmentation method based on target detection | 温州市人民医院 | 2025-06-17 | — | — | CN | claimed |
| CN-120164360-A | Lumbar puncture training system | 温州市人民医院 | 2025-06-17 | — | — | CN | claimed |
| EP-4565325-A2 | FATTY ACID-D-AMINO ACID PEPTIDES CONJUGATES AS ANAPLEROTIC COMPOUNDS FOR USE IN TREATING PROPIONIC ACIDEMIA, METHYLMALONIC ACIDURIAS, AND ENERGY METABOLIC DISORDERS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-06-11 | — | — | EP | claimed |
| CN-120031179-A | Instrument sharing platform operation success prediction method based on machine learning algorithm | 浙江农林大学 | 2025-05-23 | — | — | CN | claimed |
| CN-119855613-A | Fatty acid-D-amino acid peptide conjugates as anaplerotic compounds for the treatment of hyperuricemia, methylmalonic urine disorder and energy metabolism disorders | 匹兹堡大学高等教育联邦体系 | 2025-04-18 | — | — | CN | claimed |
| EP-4536256-A2 | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Siolta Therapeutics, Inc. (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119828580-A | Automatic compensation control system for treating wire rod iron scale | 贵州航天南海科技有限责任公司 | 2025-04-15 | — | — | CN | claimed |
| WO-2016196281-A1 | MTAP INHIBITORS FOR THE TREATMENT OF SICKLE CEMTAP DISEASE | NANOMETICS LLC (US) | 2016-12-08 | — | — | WO | claimed |
| WO-2015127163-A1 | PYRIDOXAMINE FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA AND RELATED BLOOD DISEASES | PHD BIOSCIENCES ( FORMERLY NANOMETICS LLC) (US) | 2015-08-27 | — | — | WO | claimed |
| US-8618068-B2 | Methods and low dose regimens for treating red blood cell disorders | TRUSTEES OF BOSTON UNIVERSITY (US) | 2013-12-31 | — | — | US | claimed |
| EP-2509418-A1 | METHODS AND LOW DOSE REGIMENS FOR TREATING RED BLOOD CELL DISORDERS | Hemaquest Pharmaceuticals, Inc. (US) | 2012-10-17 | — | — | EP | claimed |
| WO-2011072086-A9 | METHODS AND LOW DOSE REGIMENS FOR TREATING RED BLOOD CELL DISORDERS | HEMAQUEST PHARMACEUTICALS, INC. (US) | 2012-09-27 | — | — | WO | claimed |
| EP-2380571-A1 | BIOSYNTHESIS OF DERIVATIVES OF MONACOLIN J | Neuron Biopharma, S.A. (ES) | 2011-10-26 | — | — | EP | claimed |
| US-20110251149-A1 | METHODS AND LOW DOSE REGIMENS FOR TREATING RED BLOOD CELL DISORDERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2011-10-13 | — | — | US | claimed |
| US-20110189726-A1 | BIOSYNTHESIS OF DERIVATIVES OF MONACOLIN J | NEURON BIOPHARMA, S.A. (ES) | 2011-08-04 | — | — | US | claimed |
| WO-2011072086-A1 | METHODS AND LOW DOSE REGIMENS FOR TREATING RED BLOOD CELL DISORDERS | HEMAQUEST PHARMACEUTICALS, INC. (US) | 2011-06-16 | — | — | WO | claimed |
| US-7265153-B2 | Compositions and methods for the treatment of cystic fibrosis | TRUSTEES OF BOSTON UNIVERSITY | 2007-09-04 | — | — | US | claimed |